| 标题 |
Role of ctDNA in predicting the outcome of patients with hormone receptor–positive, HER2-negative advanced breast cancer treated with first-line ribociclib and letrozole: BioItaLEE trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:Giampaolo Bianchini; Luca Malorni; Roberta Caputo; Alberto Zambelli; Fabio Puglisi; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)